Game-changing bone marrow kit from SurGenTec gets FDA approval—find out why it’s a big deal
In a significant leap forward for orthopedic and spine technology, SurGenTec, a leading medical device company, has secured 510(k) clearance from the U.S. Food and ... Read More
Revolutionary nerve healing discovered! How your gums could restore your face
At Penn Dental Medicine, Dr. Ahn Le, the Norman Vine Endowed Professor of Oral Rehabilitation, is leading a groundbreaking approach to nerve repair in the ... Read More
ENCell announces promising results from Phase 1 CMT1A trial of EN001
ENCell Co., Ltd., a South Korean biotech leader specializing in Cell and Gene Therapy (CGT), has unveiled promising results from their first-in-human Phase 1 clinical ... Read More
Oncocross and JW Pharmaceutical forge new path in AI-driven drug development
In a significant stride toward revolutionizing drug discovery and development, Seoul-based biotech firm Oncocross announced on May 22nd a renewed joint research agreement with JW ... Read More
Cynata Therapeutics wraps up patient enrollment for diabetic foot ulcers clinical trial
In a significant development for diabetic foot ulcer treatments, Cynata Therapeutics Limited (ASX: CYP), a leading clinical-stage biotechnology company, has announced the completion of patient ... Read More
Humacyte to merge with Alpha Healthcare Acquisition Corp in $1.1bn deal to advance regenerative medicine
Humacyte, Inc., a clinical-stage biotech company based in Durham, North Carolina, has announced a merger with Alpha Healthcare Acquisition Corp. (AHAC), a blank check company. ... Read More